Environmental Persistence of Staphylococcus capitis NRCS-A in Neonatal Intensive Care Units: Role of Biofilm Formation, Desiccation, and Disinfectant Tolerance.


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
21 12 2022
Historique:
pubmed: 22 11 2022
medline: 28 12 2022
entrez: 21 11 2022
Statut: ppublish

Résumé

The clone Staphylococcus capitis NRCS-A is responsible for late-onset sepsis in neonatal intensive care units (NICUs) worldwide. Over time, this clone has evolved into three subgroups that are increasingly adapted to the NICU environment. This study aimed to decipher the mechanisms involved in NRCS-A persistence in NICUs. Twenty-six

Identifiants

pubmed: 36409142
doi: 10.1128/spectrum.04215-22
pmc: PMC9769769
doi:

Substances chimiques

Anti-Bacterial Agents 0
Disinfectants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0421522

Références

Microorganisms. 2021 Dec 10;9(12):
pubmed: 34946151
Diagn Microbiol Infect Dis. 2019 Aug;94(4):337-341
pubmed: 30885396
J Antimicrob Chemother. 2013 Oct;68(10):2226-33
pubmed: 23739538
J Med Microbiol. 2005 Jun;54(Pt 6):557-565
pubmed: 15888465
Arch Microbiol. 2011 Feb;193(2):125-35
pubmed: 21088825
Pediatr Res. 2021 Dec;90(6):1215-1220
pubmed: 33627818
Pediatrics. 2013 Aug;132(2):e372-80
pubmed: 23878051
Antimicrob Resist Infect Control. 2019 Oct 17;8:157
pubmed: 31636900
J Hosp Infect. 2021 Oct;116:87-90
pubmed: 34419520
Food Microbiol. 2018 Feb;69:82-88
pubmed: 28941912
PLoS One. 2012;7(2):e31548
pubmed: 22348102
J Clin Med. 2019 Nov 02;8(11):
pubmed: 31684101
Appl Environ Microbiol. 2019 Jun 17;85(13):
pubmed: 31028024
Sci Rep. 2018 Aug 29;8(1):13040
pubmed: 30158585
APMIS. 2007 Aug;115(8):891-9
pubmed: 17696944
Emerg Infect Dis. 2017 Mar;23(3):538-539
pubmed: 28221122
Clin Infect Dis. 2008 Jan 15;46(2):274-81
pubmed: 18171263
Stand Genomic Sci. 2014 Apr 15;9(3):1118-27
pubmed: 25197487
Pediatr Infect Dis J. 2005 Jun;24(6):566-7
pubmed: 15933574
J Hosp Infect. 2016 Jul;93(3):263-70
pubmed: 27140421
J Med Microbiol. 2015 Jun;64(6):591-604
pubmed: 25813821
Early Hum Dev. 2012 May;88 Suppl 2:S69-74
pubmed: 22633519
Front Microbiol. 2020 May 13;11:920
pubmed: 32477314
Infect Disord Drug Targets. 2021;21(3):459-463
pubmed: 32389116
Vet Microbiol. 2014 Aug 27;172(3-4):511-8
pubmed: 24984943
Proc Biol Sci. 2018 Jun 13;285(1880):
pubmed: 29899074
Microbiol Mol Biol Rev. 2020 Aug 12;84(3):
pubmed: 32792334
J Clin Microbiol. 2000 Feb;38(2):724-6
pubmed: 10655374
Pathogens. 2021 Feb 04;10(2):
pubmed: 33557202
Antimicrob Agents Chemother. 2002 Sep;46(9):2797-803
pubmed: 12183231
J Hosp Infect. 2013 Apr;83(4):333-6
pubmed: 23414707
Nat Microbiol. 2020 May;5(5):735-745
pubmed: 32341568
Front Microbiol. 2016 Dec 15;7:1991
pubmed: 28018320
Front Microbiol. 2017 Jul 20;8:1359
pubmed: 28775716
J Clin Microbiol. 2010 Nov;48(11):3876-81
pubmed: 20826641
Antimicrob Agents Chemother. 2018 Oct 24;62(11):
pubmed: 30150477
J Allergy Clin Immunol. 2010 Dec;126(6):1184-90.e3
pubmed: 21036388
J Surg Res. 2012 Oct;177(2):334-40
pubmed: 22682712
J Microbiol Methods. 2014 Oct;105:102-4
pubmed: 25017901
J Hosp Infect. 2021 Jun;112:54-60
pubmed: 33640370
Microbiology (Reading). 2008 Jun;154(Pt 6):1755-1762
pubmed: 18524930
Antimicrob Agents Chemother. 2013 Aug;57(8):3488-97
pubmed: 23669380
J Hosp Infect. 2021 May;111:148-154
pubmed: 33581246
PLoS One. 2017 Aug 31;12(8):e0184172
pubmed: 28859149
Am J Perinatol. 2015 Jun;32(7):675-82
pubmed: 25486288
J Infect Public Health. 2018 Nov - Dec;11(6):801-806
pubmed: 29784578
Semin Perinatol. 2012 Dec;36(6):437-44
pubmed: 23177803
Front Microbiol. 2020 Jun 30;11:1368
pubmed: 32714301
Infect Control Hosp Epidemiol. 2023 Jan;44(1):40-46
pubmed: 35311638
Eur J Pediatr. 2019 Apr;178(4):505-513
pubmed: 30671695
Med Princ Pract. 2019;28(1):28-35
pubmed: 30352435
Front Microbiol. 2018 Nov 14;9:2687
pubmed: 30487781
J Hosp Infect. 2015 Sep;91(1):35-44
pubmed: 26187533
Front Microbiol. 2016 Jun 06;7:856
pubmed: 27375578
ACS Nano. 2016 Mar 22;10(3):3443-52
pubmed: 26908275
BMC Infect Dis. 2019 Feb 27;19(1):199
pubmed: 30813914
J Antimicrob Chemother. 2012 Nov;67(11):2547-59
pubmed: 22833635
BMC Genomics. 2018 Nov 8;19(1):810
pubmed: 30409159

Auteurs

Marie Chavignon (M)

Centre International de Recherche en Infectiologie (CIRI), Team Pathogénie des Staphylocoques, INSERM U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, Lyon, France.

Ludivine Coignet (L)

Centre International de Recherche en Infectiologie (CIRI), Team Pathogénie des Staphylocoques, INSERM U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, Lyon, France.

Mélanie Bonhomme (M)

Centre International de Recherche en Infectiologie (CIRI), Team Pathogénie des Staphylocoques, INSERM U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, Lyon, France.

Marine Bergot (M)

Centre International de Recherche en Infectiologie (CIRI), Team Pathogénie des Staphylocoques, INSERM U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, Lyon, France.

Anne Tristan (A)

Centre International de Recherche en Infectiologie (CIRI), Team Pathogénie des Staphylocoques, INSERM U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, Lyon, France.
Institut des Agents Infectieux, Centre National de Référence des Staphylocoques, Hospices Civils de Lyon, Lyon, France.

Paul Verhoeven (P)

Centre International de Recherche en Infectiologie (CIRI), Team GIMAP (Groupe sur l'Immunité des Muqueuses et Agents Pathogènes), INSERM U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, Lyon, France.
Department of Infectious Agents and Hygiene, University-Hospital of Saint-Etienne, Saint-Etienne, France.

Jérôme Josse (J)

Centre International de Recherche en Infectiologie (CIRI), Team Pathogénie des Staphylocoques, INSERM U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, Lyon, France.

Frédéric Laurent (F)

Centre International de Recherche en Infectiologie (CIRI), Team Pathogénie des Staphylocoques, INSERM U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, Lyon, France.
Institut des Agents Infectieux, Centre National de Référence des Staphylocoques, Hospices Civils de Lyon, Lyon, France.

Marine Butin (M)

Centre International de Recherche en Infectiologie (CIRI), Team Pathogénie des Staphylocoques, INSERM U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, Lyon, France.
Service de Néonatologie et Réanimation Néonatale, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH